The follicular lymphoma microenvironment: From tumor cell to host immunity

Current Hematologic Malignancy Reports

Volumn 3, Issue 4, 2008, Pages 179-186

  Martinez, Antonio ^a   Carreras, Joaquim ^a   Campo, Elias ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; PROTEIN BCL 2;

CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RISK; CANCER SURVIVAL; CELL INTERACTION; CELL SUBPOPULATION; CELL TRANSFORMATION; CYTOKINE PRODUCTION; DEREGULATION; FOLLICULAR DENDRITIC CELL; FOLLICULAR LYMPHOMA; GENE MUTATION; GENE TRANSLOCATION; GERMINAL CENTER; HELPER CELL; HISTIOCYTE; HUMAN; IMMUNE RESPONSE; MICROENVIRONMENT; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STROMA CELL; TUMOR IMMUNITY;

CYTOKINES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMINAL CENTER; HUMANS; IMMUNOTHERAPY; LYMPHOMA, FOLLICULAR; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 59249097195     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-008-0026-6     Document Type: Review

References (43)

1. de Jong D: Molecular pathogenesis of follAcular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005, 23:6358-6363.
2. Dave SS, Wright G, Tan B, et al.: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004, 351:2159-2169.
3. Glas AM, Kersten MJ, Delahaye LJ, et al.: Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005, 105:301-307.
4. Glas AM, Knoops L, Delahaye L, et al.: Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007, 25:390-398.
5. Husson H, Carideo EG, Neuberg D, et al.: Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002, 99:282-289.
6. Sato E, Olson SH, Ahn J, et al.: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005, 102:18538-18543.
7. Galon J, Costes A, Sanchez-Cabo F, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
8. Rosenberg SA, RestAfo NP, Yang JC, et al.: Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8:299-308.
9. Schultze JL, Seamon MJ, Michalak S, et al.: Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood 1997, 89:3806-3816.
10. Farinha P, Gascoyne RD: Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005, 23: 6370-6378.
11. Rohatiner AZ, Gregory WM, Peterson B, et al.: Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol 2005, 23:2215-2223.
12. Farinha P, Masoudi H, Skinnider BF, et al.: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005, 106:2169-2174.
13. Carreras J, Lopez-Guillermo A, Fox BC, et al.: High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006, 108:2957-2964.
14. Byers RJ, Sakhinia E, Joseph P, et al.: Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 2008, 111:4764-4770.
15. Alvaro T, Lejeune M, Camacho FI, et al.: The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica 2006, 91:1605-1612.
16. Jaffe ES, Shevach EM, Frank MM, et al.: Nodular lymphoma - evidence for origin from follicular B lymphocytes. N Engl J Med 1974, 290:813-819.
17. Bende RJ, Smit LA, van Noesel CJ: Molecular pathways in follicular lymphoma. Leukemia 2007, 21:18-29.
18. Klein U, DelR-Favera R: Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008, 8:22-33.
19. Cong P, Raffeld M, Teruya-Feldstein J, et al.: In situ localization of follicular lymphoma: Description and analysis by laser capture microdissection. Blood 2002, 99:3376-3382.
20. Gine E, Montoto S, Bosch F, et al.: The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol 2006, 17:1539-1545.
21. Bohen SP, Troyanskaya OG, Alter O, et al.: Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A 2003, 100:1926-1930.
22. Rademakers LH, Peters JP, van Unnik JA: Histiocytic and dendritic reticulum cells in follicular structures of follicular lymphoma and reactive hyperplasia. A quantitative electron microscopical analysis. Virchows Arch B Cell Pathol Incl Mol Pathol 1983, 44:85-98.
23. Alvaro T, Lejeune M, Salvadó MT, et al.: Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006, 24:5350-5357.
24. Lee AM, Clear AJ, Calaminici M, et al.: Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006, 24:5052-5059.
25. Banham AH, Powrie FM,CSuri-Payer E: FOXP3+ regulatory T cells: current controversies and future perspectives. Eur J Immunol 2006, 36:2832-2836.
26. Lim HW, Hillsamer P, Kim CH: Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004, 114:1640-1649.
27. Zhao D-M, Thornton AM, Dipaolo RJ, Shevach EM: Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006, 107:3925-3932.
28. King C, Tangye SG, Mackay CR: T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008, 26:741-766.
29. Haynes NM, Allen CD, Lesley R, et al.: Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1 high germinal center-associated subpopulation. J Immunol 2007, 179:5099-5108.
30. Roncador G, García Verdes-Montenegro JF, Tedoldi S, et al.: Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007, 92:1059-1066.
31. Canioni D, Salles G, Mounier N, et al.: High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008, 26:440-446.
32. Mantovani A, Sica A, Locati M: New vistas on macrophage differentiation and activation. Eur J Immunol 2007, 37:14-16.
33. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
34. Park CS, Choi YS: How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 2005, 114:2-10.
35. Chang KC, Huang X, Medeiros LJ, Jones D: Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol 2003, 201:404-412.
36. Clayberger C, Luna-Fineman S, Lee JE, et al.: Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med 1992, 175:371-376.
37. Peuchmaur M, Emilie D, Crevon MC, et al.: Interleukin-2 and interferon-gamma production in follicular lymphomas. Am J Clin Pathol 1991, 95:55-62.
38. Fujii A, Oshima K, Hamasaki M, et al.: Differential expression of cytokines, chemokines and their receptors in follicular lymphoma and reactive follicular hyperplasia: Assessment by complementary DNA microarray. Oncol Rep 2005, 13:819-824.
39. Akamatsu N, Yamada Y, Hasegawa H, et al.: High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma. Cancer Lett 2007, 256:196-206.
40. Martinez A, Pittaluga S, Rudelius M, et al.: Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: A novel germinal center marker. Am J Surg Pathol 2008, 32:1190-1200.
41. Karube K, Guo Y, Suzumiya J, et al.: CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 2007, 109:3076-3079.
42. Cerhan JR, Ansell SM, Fredericksen ZS, et al.: Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007, 110:4455-4463.
43. Nieters A, Beckmann L, Deeg E, Becker N: Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006, 7:615-624.